Shenzhen Qinggan Biotechnology
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Shenzhen Qinggan Biotechnology - overview
Established
2020
Location
Shenzhen, Guangdong, China
Primary Industry
Food
About
Based in Shenzhen, China, and founded in 2020, Shenzhen Qinggan Biotechnology is a healthcare company specializing in the field of anti-aging of the female organism. It has laboratories and in-house production lines in the U. S. and Canada.
The company mainly engaged in the development of anti-aging products. Its brand Hiiwer originates from the United States and is positioned as a mid-to-high-end series of nutritional products. At present, the Hiiwer product line mainly includes NMN for comprehensive anti-aging, anti-sugar pills, whitening pills, and other body-related anti-aging products. Hiiwer series products have generated total sales of CNY 50 million from its official launch in September 2021 to March 2022.
Among them, in a single month in December 201, sales exceeded more than CNY 20 million. In the future, it plans to establish a brand matrix to expand the target group from women to men, the elderly, and children who also have the need to consume dietary supplements.
Current Investors
Shunfu Capital, Hainan Chengjia Jiye Investment
Primary Industry
Food
Sub Industries
Health Foods & Nutritional Supplements, Healthcare
Verticals
E-commerce
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.